154 related articles for article (PubMed ID: 10229343)
1. Effects of oral administration of the competitive N-methyl-D-aspartate antagonist, CGP 40116, on passive avoidance, spatial learning, and neuromotor abilities in mice.
Hauben U; D'Hooge R; Soetens E; De Deyn PP
Brain Res Bull; 1999 Feb; 48(3):333-41. PubMed ID: 10229343
[TBL] [Abstract][Full Text] [Related]
2. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
[TBL] [Abstract][Full Text] [Related]
3. Effects of the competitive NMDA receptor antagonist CGP 37849 on performance of reference and working memory tasks by rats.
Deacon RM; Rawlins JN
Eur J Pharmacol; 1995 Jul; 280(2):239-42. PubMed ID: 7589194
[TBL] [Abstract][Full Text] [Related]
4. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
Ylinen A; Pitkänen M; Sirviö J; Hartikainen T; Sivenius J; Koivisto E; Riekkinen PJ
Eur J Pharmacol; 1995 Feb; 274(1-3):159-65. PubMed ID: 7768268
[TBL] [Abstract][Full Text] [Related]
5. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on ischemic brain damage induced by four-vessel occlusion in rats.
Okada M; Fujimura Y; Ueda H; Kometani M; Nakao K; Inukai T
Arzneimittelforschung; 1997 Feb; 47(2):115-9. PubMed ID: 9079228
[TBL] [Abstract][Full Text] [Related]
6. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
[TBL] [Abstract][Full Text] [Related]
7. Ca2+ channel blockade and the antielectroshock activity of NMDA receptor antagonists, CGP 40116 and CGP 43487, in mice.
Gasior M; Borowicz K; Starownik R; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1996 Sep; 312(1):27-33. PubMed ID: 8891575
[TBL] [Abstract][Full Text] [Related]
8. Blockade of N-methyl-D-aspartate receptors in the insular cortex disrupts taste aversion and spatial memory formation.
Gutiérrez H; Hernández-Echeagaray E; Ramírez-Amaya V; Bermúdez-Rattoni F
Neuroscience; 1999 Mar; 89(3):751-8. PubMed ID: 10199610
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
Chapman AG; Graham JL; Patel S; Meldrum BS
Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
[TBL] [Abstract][Full Text] [Related]
10. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
Wlaź P
Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptors in the medial septal area have a role in spatial and emotional learning in the rat.
Elvander-Tottie E; Eriksson TM; Sandin J; Ogren SO
Neuroscience; 2006 Nov; 142(4):963-78. PubMed ID: 16952425
[TBL] [Abstract][Full Text] [Related]
12. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
[TBL] [Abstract][Full Text] [Related]
14. The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice.
Mathis C; Vogel E; Cagniard B; Criscuolo F; Ungerer A
Neuropharmacology; 1996; 35(8):1057-64. PubMed ID: 9121608
[TBL] [Abstract][Full Text] [Related]
15. Ketamine affects memory consolidation: differential effects in T-maze and passive avoidance paradigms in mice.
Wang JH; Fu Y; Wilson FA; Ma YY
Neuroscience; 2006 Jul; 140(3):993-1002. PubMed ID: 16600517
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia.
Okada M; Ueda H; Kometani M; Nakao K; Kohjimoto Y; Takahashi I; Tanaka I
Arzneimittelforschung; 1997 Jun; 47(6):700-2. PubMed ID: 9239445
[TBL] [Abstract][Full Text] [Related]
17. Competitive NMDA receptor antagonists and agonists: effects on spontaneous alternation in mice exposed to cerebral oligemia.
Jóźwiak L; Łukawski K; Czuczwar SJ; Sieklucka-Dziuba M
Pol J Pharmacol; 2004; 56(1):59-66. PubMed ID: 15047978
[TBL] [Abstract][Full Text] [Related]
18. Locomotor activity and motor disturbances induced by the competitive NMDA receptor antagonist CGP 37849.
Kolasiewicz W; Maj J
Pol J Pharmacol; 1996; 48(5):467-79. PubMed ID: 9112688
[TBL] [Abstract][Full Text] [Related]
19. Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol.
Bienkowski P; Stefanski R; Kostowski W
Eur J Pharmacol; 1996 Oct; 314(3):277-80. PubMed ID: 8957246
[TBL] [Abstract][Full Text] [Related]
20. Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.
De Sarro G; De Sarro A; Ammendola D; Patel S
Brain Res; 1996 Sep; 734(1-2):91-7. PubMed ID: 8896813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
